DOI: 10.25881/BPNMSC.2020.91.25.016

Authors

Shahnazaryan N.G.1, Ajdemirov A.N.2, 3, Hurcev K.V.1, Kojchuev A.A.1, 2, Shahnazaryan A.M.2, Gridasov I.M.1

1 Stavropol regional clinical Oncology center, Stavropol

2 Stavropol state medical University, Stavropol

3 Stavropol regional clinical hospital, Stavropol

Abstract

Backgraund: the annual increase in the incidence of pancreatic cancer, disappointing results of treatment, a high percentage of complications and deaths prompted us to conduct our own analysis of morbidity and mortality from pancreatic malignancies in the Stavropol territory and the Russian Federation.

The aim of the study is to study the prevalence, morbidity and mortality of patients with malignant tumors of the pancreas in the Stavropol territory, a comparative analysis of the incidence and mortality from pancreatic cancer in the Stavropol territory and the Russian Federation.

Materials and methods: a review of the data of specialized literature on the problem of morbidity, mortality and results of treatment of pancreatic cancer in the Russian Federation and the Stavropol territory for the period from 2011 to 2018.

Results: over the 8-year period of the study, there is a tendency to increase the prevalence of pancreatic cancer, both in the Russian Federation and in the Stavropol territory. It was found that men of retirement age suffer from pancreatic cancer more often, but there was an annual increase in patients of working age. There was a high proportion of patients who applied for the first time to a medical institution with stage IV disease (up to 58%). Also, the long-term results of treatment of malignant tumors of the pancreas to date remain extremely unsatisfactory.

Conclusion: this study allows us to realistically assess the situation on the prevalence, morbidity and mortality of patients with BC in the Stavropol territory and the Russian Federation.

Keywords: epidemiology, pancreatic cancer, morbidity, mortality.

References

1. Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu (zabolevaemost’ i smertnost’). Ed by Kaprin A.D., Starinsky V.V., Petrovа G.V. Moscow: MNIOI im. P. A. Herzen, branch of FSBI «NMITS radiology» of the Ministry of health of Russia; 2018. 250 p. (In Russ).

2. Sostojanie onkologicheskoi pomoshchi naseleniju Rossii v 2016 godu. Ed by Kaprin A.D., Starinskii V.V., Petrova G.V. Moscow: MNIOI im. P. A. Herzen, branch FGBI «NERC» Ministry of health of Russia; 2017. 236 p. (In Russ).

3. Patyutko YuI, Kudashkin NE, Kotel’nikov AG, Chistyakova OV. Total pancreatectomy for pancreatic cancer. Khirurgia. 2016;(9):13-20. (In Russ).

4. Statistika zlokachestvennyh novoobrazovanij v Rossii i stranah SNG v 2012 g. Ed by Davydov M.I., Aksel’ E.M. Moscow: RONC Publishing group; 2014. 226 p. (In Russ).

5. Duell EJ, Lucenteforte E, Olson SH, et al. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012;23(11):2964-2970. Doi: 10.1093/annonc/mds140.

6. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6(12):699-708. Doi: 10.1038/nrgastro.2009.177.

7. Sidorenko AM, Shevchenko AI, Kugaenko IS. Epidemiology of pancreatic cancer in the XX and early XXI century. Patologiya. 2013;(1):10-13. (In Russ).

8. Zlokachestvennye novoobrazovanija v Rossii v 2013 godu (zabolevaemost’ i smertnost’). Ed by Kaprin A.D., Starinsky V.V., Petrovа G.V. Moscow: RIIS FIAN; 2015. 140 p. (In Russ).

9. Zlokachestvennye novoobrazovanija v Rossii v 2013 godu (zabolevaemost’ i smertnost’). Ed by Kaprin A.D., Starinsky V.V., Petrovа G.V. Moscow: MNIOI im. P. A. Herzen - branch FGBI «NERC» Ministry of health of Russia; 2017. 250 p. (In Russ).

10. Petrova GV, Kaprin AD, Grecova OP, Starinskii VV. Zlokachestvennye novoobrazovanija v Rossii (obzor statisticheskoj informacii za 1993-2013gg). Moscow: MNIOI im. P. A. Herzen — branch FGBI «NERC» Ministry of health of Russia; 2015. 511 p. (In Russ).

11. Patyutko YuI, Kotel’nikov AG, Yastrebova EV, et al. Pancreatic ductal cancer surgery. Annaly khirurgicheskoi gepatologii. 2017;22(4):18-30. (In Russ). Doi: 10.16931/1995-5464.2017418-30.

12. Revishvili ASh, Kriger AG, Vishnevskii VA, et al. Actual questions of surgery of the pancreas. Khirurgia. 2018;(9):5-14. (In Russ). Doi: 10.17116/hirurgia20180915.

13. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2015 godu. Ed by Kaprin A.D., Starinskii V.V., Petrova G.V. Moscow: RIIS FIAN; 2016. 236 p. (In Russ).

14. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2018 godu. Ed by Kaprin A.D., Starinskii V.V, Petrova G.V. Moscow: MNIOI im. P. A. Herzen - branch of FSBI «NMITS radiology» of the Ministry of health of Russia; 2019. 236 p. (In Russ).

15. Natal’skii AA, Tarasenko SV, Zaitsev OV, et al. Modern aspects of the prevalence of mechanical jaundice syndrome. Vestnik Natsional’nogo mediko-khirurgicheskogo Tsentra im. N.I. Pirogova. 2014;9(3):55-60. (In Russ).

16. Fogelman D, Sugar EA, Oliver G, et al. Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma. Cancer Chemother Pharmacol. 2015;76(3):489-498. Doi: 10.1007/s00280-015-2788-6.

For citation

Shahnazaryan N.G., Ajdemirov A.N., Hurcev K.V., Kojchuev A.A., Shahnazaryan A.M., Gridasov I.M. Epidemiological study of the prevalence of malignant neoplasms of the pancreas in the Stavropol territory. Bulletin of Pirogov National Medical & Surgical Center. 2020;15(1):84-88. (In Russ.) https://doi.org/10.25881/BPNMSC.2020.91.25.016